AUSTRALASIA
Clarified scope of pharmaceutical patent term extensions
In Australia, it is possible to apply for a patent term extension (PTE) of up to 5 years for patents relating to pharmaceutical substances.  To be eligible for a...
In Australia, it is possible to apply for a patent term extension (PTE) of up to 5 years for...
Read More
SOUTHEAST ASIA
Winthrop Pharmaceuticals (Malaysia) Sdn Bhd v Astrazeneca UK Limited
The High Court of Malaysia has delivered its judgment in Winthrop Pharmaceuticals (Malaysia) Sdn Bhd v Astrazeneca UK Limited, in which Spruson & Ferguson Asia Pte Ltd successfully assisted...
The High Court of Malaysia has delivered its judgment in Winthrop Pharmaceuticals (Malaysia) Sdn Bhd v Astrazeneca UK Limited,...
Read More
The Indian patent office strikes again
The Indian patent office strikes again – patent application refused as chemical variant of known compound is not considered an invention according to Section 3(d) In a recent decision, the...
The Indian patent office strikes again – patent application refused as chemical variant of known compound is not considered...
Read More
AUSTRALASIA
Midmark Corporation v Ritter Concept GmbH [2014] ATMO 106
The Opponent (Midmark Corporation) was successful in its opposition to extension of protection for an International Registration Designating Australia (IRDA) filed in the name of Ritter Concept Gmbh. The...
The Opponent (Midmark Corporation) was successful in its opposition to extension of protection for an International Registration Designating Australia...
Read More
AUSTRALASIA
Johnson & Johnson v Self Care Corporation Pty Ltd [2014] ATMO 111
The application that was the subject of this matter (ALFREE) was a divisional application from the parent trade mark AlFREE. The divisional was objected to by the Trade Marks...
The application that was the subject of this matter (ALFREE) was a divisional application from the parent trade mark...
Read More
AUSTRALASIA
GlaxoSmithKline LLC, SmithKline Beecham (Australia) Pty Ltd and SmithKline Beecham Limited v AFT Pharmaceuticals Limited [2014] ATMO 100
Application by AFT Pharmaceuticals Limited to register its “PARACETAMOL OSTEO-TAB” trademark was opposed by three companies. Considering section 41 first, the Hearing Officer came to the view that the opposed...
Application by AFT Pharmaceuticals Limited to register its “PARACETAMOL OSTEO-TAB” trademark was opposed by three companies. Considering section 41 first,...
Read More
AUSTRALASIA
Australian IP Amendment Bill Tackles Trans-Tasman Initiatives and TRIPS Protocol
As Australian patent applicants, their representatives, and the Australian Patent Office settle into life after the substantial changes to patents legislation brought about by the Intellectual Property Laws Amendment...
As Australian patent applicants, their representatives, and the Australian Patent Office settle into life after the substantial changes to...
Read More
AUSTRALASIA
High Court Grants Extension of Time for Extending Patent Term
As discussed in a previous blog, Australian patent law permits many deadlines to be extended in the event that a critical date is missed. Provided that an applicant or...
As discussed in a previous blog, Australian patent law permits many deadlines to be extended in the event that...
Read More
AUSTRALASIA
Insight Clinical Imaging v Insight Radiology Pty Ltd [2014] ATMO 85
Application for the below trade mark opposed by Insight Clinical. The opponent alleged that it was the owner of the applied for trade mark as it was substantially identical to...
Application for the below trade mark opposed by Insight Clinical. The opponent alleged that it was the owner of the...
Read More
AUSTRALASIA
Novartis AG v Obvieline [2014] ATMO 79
Novartis opposed the Australian designation of Obvieline’s International Registration for SYNECTHA, covering pharmaceutical goods in Class 5. The opposition was based largely on the opponent’s prior SYNACTHEN registration, which also...
Novartis opposed the Australian designation of Obvieline’s International Registration for SYNECTHA, covering pharmaceutical goods in Class 5. The opposition was...
Read More